Tema Oncology ETF (CANC)
NASDAQ: CANC · Real-Time Price · USD
37.18
-0.29 (-0.77%)
At close: Jun 16, 2026, 4:00 PM EDT
37.10
-0.08 (-0.22%)
After-hours: Jun 16, 2026, 4:15 PM EDT
CANC Holdings Information
CANC is an equity ETF with a total of 60 individual holdings. The top holdings are Revolution Medicines stock at 6.25%, Eli Lilly and Company at 5.31%, Legend Biotech at 4.69%, Novartis AG at 4.45%, and Cogent Biosciences at 4.26%.
Total Holdings
60
Top 10 Percentage
43.12%
Asset Class
Equity
ETF Category
Health
Assets
178.42M
PE Ratio
19.80
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | RVMD | Revolution Medicines, Inc. | 6.25% |
| 2 | LLY | Eli Lilly and Company | 5.31% |
| 3 | LEGN | Legend Biotech Corporation | 4.69% |
| 4 | SWX: NOVN | Novartis AG | 4.45% |
| 5 | COGT | Cogent Biosciences, Inc. | 4.26% |
| 6 | RHHBY | Roche Holding AG | 4.24% |
| 7 | MRK | Merck & Co., Inc. | 3.66% |
| 8 | BMY | Bristol-Myers Squibb Company | 3.57% |
| 9 | IMNM | Immunome, Inc. | 3.36% |
| 10 | NUVL | Nuvalent, Inc. | 3.34% |
| 11 | LON: AZN | AstraZeneca PLC | 3.25% |
| 12 | JNJ | Johnson & Johnson | 3.16% |
| 13 | ABBV | AbbVie Inc. | 3.00% |
| 14 | EXEL | Exelixis, Inc. | 2.99% |
| 15 | BBIO | BridgeBio Pharma, Inc. | 2.84% |
| 16 | AMGN | Amgen Inc. | 2.78% |
| 17 | CGON | CG Oncology, Inc. | 2.37% |
| 18 | GMAB | Genmab A/S | 2.31% |
| 19 | IDYA | IDEAYA Biosciences, Inc. | 2.28% |
| 20 | CELC | Celcuity Inc. | 2.10% |
| 21 | ONC | BeOne Medicines AG | 1.76% |
| 22 | ZLAB | Zai Lab Limited | 1.72% |
| 23 | ELVN | Enliven Therapeutics, Inc. | 1.62% |
| 24 | ZYME | Zymeworks Inc. | 1.40% |
| 25 | RLAY | Relay Therapeutics, Inc. | 1.38% |
As of Jun 12, 2026